European Patent Office

T 1113/12 (Use of GM-CSF and a type 1 interferon for treating multiple sclerosis/HUNTER) of 18.02.2016

European Case Law Identifier
ECLI:EP:BA:2016:T111312.20160218
Date of decision
18 February 2016
Case number
T 1113/12
Petition for review of
-
Application number
03776426.3
IPC class
A61K 38/19
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Method for treatment of demyelinating central nervous system disease using GM-CSF
Applicant name
Hunter, Samuel F.
Opponent name
-
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
Keywords
Main request: requirements of the EPC met (yes)
Catchword
-
Citing cases
-

Order

For these reasons it is decided that:

- The decision under appeal is set aside.

- The case is remitted to the examining division with the order to grant a patent on the basis of the claims of the main request as filed at the oral proceedings and a description and figures to be adapted thereto.